Notify me when Timothy A. Springer files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| RNAC | Cartesian Therapeutics, Inc. | Common Stock, $0.0001 par value per share | 36.9% | $117M | $259K | 9.56M | +0.22% | Timothy A. Springer | Jan 13, 2025 |
| TECX | Tectonic Therapeutic, Inc. | Common Stock, $0.0001 par value per share | 31.5% | $96.5M | $1.96M | 4.31M | +2.07% | Timothy A. Springer | Apr 3, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|